3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
3
Neoplasms
2
Obesity
1
Leukemia, Myeloid, Acute
1
Hyperandrogenism
1
Heart Failure
1
Critical Illness
1
Cardiotoxicity
1
Acute Kidney Injury
1
Interventions
Ivabradine
2
Watchful Waiting
1
Standard of Care
1
Spironolactone
1
Secondary Prevention
1
Population Groups
1
Perindopril
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Exercise
1
Control Groups
1
Blood Specimen Collection
1
Bisoprolol
1
Atorvastatin
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Heart Failure
×
Spironolactone
×
Clear all
NCT06005259
2023-08-22
SPIROTOX
University of Sao Paulo
Phase 4
Unknown
264 enrolled